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Interventional Cardiology
Meta-Analysis Finds Similar Efficacy for PES and SES in Diabetics
Mahmudand colleagues performed ameta-analysis to estimate and compare ratesof revascularization and major adverse cardiac events (MACE) in diabetic
patients treated with paclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES).
In 13 randomized trials with over 2,000 diabetic patients, there were no differences in
rates of target lesion revascularization, target vessel revascularization, orMACE.Similar
results were found in registries that enrolled over 10,000 subjects withmore real-world
circumstances. These data suggest that there is similar clinical efficacy for PES and SES
in diabetics; both stents show rates of revascularization 10%. See page 2385.
See figure.
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Acute Coronary Syndromes
Higher Clot Burden With ST Than With De Novo STEMI
The presentation of stent thrombosis (ST) is often an ST-segment elevationmyocardial infarction (STEMI). Chechi and colleagues compared outcomes and
procedural success rates from92 patients with STEMI due to STwith 98 patients with
de novo STEMI. All patients underwent primary percutaneous coronary intervention.
Patients with ST had a lower likelihood of successful reperfusion, higher distal embo-
lization rates, and higher rates of in-hospital major adverse cardiovascular events. Stent
thrombosis identifies a subgroup of STEMI patients with poor angiographic and early
clinical outcomes; further research is needed to determine if these patients will benefit
from interventions to reduce the clot burden, either pharmacologically or mechani-
cally. See pages 2396 and 2403. See figure.
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Heart Rhythm Disorders
Remote Steerable Sheath System for AF Ablations
The safety and success of catheter-based ablation procedures requires precisecatheter manipulation and stable contact during energy delivery. A robotic
steerable guide catheter (SGC) could improve catheter stability and allow more
freedom of movement. Saliba and colleagues studied this system in 40 subjects
undergoing radiofrequency ablation of atrial fibrillation (AF) and atrial flutter (AFL).
All pulmonary veins were successfully isolated, with good clinical success. This prelim-
inary human experience suggests that mapping and ablation of AF and AFL using a
remotely controlled robotic catheter is feasible with results comparable to the conven-
tional approach. See pages 2407 and 2412. See figure.
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Cardiac Imaging
Late Enhancement Predicts Worse Outcomes in Patients With NICM
Wu and colleagues performed a prospective cohort study of 65 subjects withnonischemic cardiomyopathy (NICM) who were evaluated for the presence
and extent of late gadolinium enhancement (LGE) by cardiac magnetic resonance.
Patientswere followed for an index composite endpoint of hospitalization, appropriate
implantable cardioverter-defibrillator firing, and cardiac death. Forty-two percent of
patients had LGE, despite no evidence of prior infarction or significant coronary artery
disease. The adjusted hazard ratio was 8.2 for those with LGE compared with those
with no LGE. The presence of LGE identifies NICM patients with worse prognosis,
possibly by indicating the replacement of myocardium with fibrous tissue. See page
2414. See figure.
Hypertension
Carotid BP May Be Better at Predicting CV Events
Pini and colleagues investigated whether central blood pressure (BP) predictscardiovascular (CV) events better than brachial BP in elderly (age 65 years)
individuals. Central blood pressurewasmeasured using applanation tonometry, which
uses an external pressure transducer applied to the skin over the common carotid artery
to derive carotid pressure waveforms. In univariate analyses, both central and brachial
systolic blood pressure (SBP) and pulse pressure (PP) predicted CV events; however
after adjusting for age and gender, only carotid SBP and PP predicted CV events. This
prospective study in a geriatric population demonstrates superior prognostic utility of
central compared with brachial BP measurements. See pages 2432 and 2440.
